According to the Statistical Yearbook of Major Surgery in 2023 published by the National Health Insurance Corporation, ...

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

Researchers from Japan successfully applied polarization-sensitive optical coherence tomography (PS-OCT) to assess various properties of the collagen fibers that make up the sclera, the outer ...

All children are at risk for developing myopia (nearsightedness); however, if one or both parents of the child has nearsightedness, the child will have a higher risk of developing nearsightedness. The ...

If approved, SYD-101 would be the first pharmaceutical treatment to slow the progression of pediatric myopia in the U.S. The FDA accepted a new drug application for SYD-101 to slow the progression ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...